Printer Friendly

RHONE-POULENC PURCHASING SHARES OF RHONE-POULENC RORER TO OFFSET DILUTIVE EVENTS

 PARIS, Feb. 11 /PRNewswire/ -- Rhone-Poulenc S.A. has decided to purchase additional shares of Rhone-Poulenc Rorer Inc. with an objective of returning its shareholding in Rhone-Poulenc Rorer towards its original level of 68.68 percent in order to offset certain dilutive events.
 Rhone-Poulenc's shareholding in Rhone-Poulenc Rorer, which stood at 68.68 percent on July 31, 1990 when Rhone-Poulenc completed the combination of its human pharmaceutical business with the Rorer Group Inc., has since such time been diluted to 66.63 percent as of Jan. 31, 1993 primarily due to Rhone-Poulenc Rorer's December 1990 public exchange offer for shares in Laboratoire Roger Bellon and the exercise over this period of stock options granted to Rhone-Poulenc Rorer's officers and directors.
 This decision demonstrates Rhone-Poulenc's confidence in the potential growth in earnings of its subsidiary at a time when Rhone- Poulenc considers that the Rhone-Poulenc Rorer share price does not reflect this. Rhone-Poulenc is acquiring shares of Rhone-Poulenc Rorer through a recently commenced program of open-market purchases on the Paris Stock Exchange that will continue for the next two or three months and may also include open-market purchases on the New York Stock Exchange.
 -0- 2/11/93
 /CONTACT: John McInerney of Dewe Rogerson, 212-688-6840/
 (RPR)


CO: Rhone-Poulenc S.A.; Rhone-Poulenc Rorer Inc. ST: IN: HEA SU:

SM-LR -- NY014 -- 5553 02/11/93 09:20 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1993
Words:224
Previous Article:REHABCLINICS STARTS OPERATION OF MINNESOTA'S TWIN CITIES MANAGED CARE
Next Article:BANCO COMERCIAL PORTUGUES CLARIFIES REPORT OF POTENTIAL CAPITAL INCREASE
Topics:


Related Articles
RHONE-POULENC RORER AGAIN INCREASES QUARTERLY DIVIDEND
RHONE-POULENC RORER AGAIN INCREASES QUARTERLY DIVIDEND
RHONE-POULENC RORER INCREASES DIVIDEND FOR 6TH CONSECUTIVE QUARTER; DIVIDENDS UP MORE THAN 100 PERCENT SINCE 1990 MERGER
GENETICS INSTITUTE PLEASED WITH BAXTER AND RHONE-POULENC RORER FACTOR VIII PATENT SETTLEMENT
BAXTER, RHONE-POULENC RORER RESOLVE ALL DISPUTES INVOLVING FACTOR VIII:C PATENTS; SIGN PURCHASING AGREEMENT FOR BAXTER PRODUCTS
Launch Of Tender Offer by Rhone-Poulenc For Shares of Rhone-Poulenc Rorer: Agreement Reached on $97 Per Share
Rhone-Poulenc S.A. Successfully Completes Tender Offer For Rhone-Poulenc Rorer Inc.
Rhone-Poulenc S.A. Completes Acquisition of Rhone-Poulenc Rorer Inc.
Rhone-Poulenc Rorer Announces Measures to Improve Productivity
Rhone-Poulenc Rorer Propharm Announces Measures to Improve Industrial Operations Competitiveness

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters